Mortality in patients with non-valvular atrial fibrillation in South America. Warfarin has significant higher global mortality rates versus dabigatran and rivaroxaban
Event:
ESC Congress 2019
Topic:
Heart Teams for Stroke Prevention
Session:
Atrial fibrillation and oral anticoagulation 4